Mesoblast’s allogeneic or ‘off-the-shelf’ regenerative medicine products focus on repair of damaged tissues and modulation of inflammatory responses in conditions with significant unmet medical needs.
Technologies
Mesoblast’s proprietary technologies include Mesenchymal Precursor Cells, culture-expanded Mesenchymal Stem Cells, Dental Pulp Stem Cells, and expanded Hematopoietic Stem Cells. Mesoblast’s allogeneic or ‘off-the-shelf’ regenerative medicine products focus on repair of damaged tissues and modulation of inflammatory responses in conditions with significant unmet medical needs.
Products
Mesoblast’s lead product candidates use its mesenchymal lineage cells in four major and distinct areas - systemic inflammatory and immunology conditions, cardiovascular diseases, orthopedic diseases of the spine and oncology.